Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain cholinergic vulnerability: relevance to behavior and disease.

Michael McKinney1, Mayo Clinic Jacksonville

  • 1Mayo Clinic, Department of Pharmacology, Jacksonville, FL 32224-3899, USA. mckinney@michael@mayo.edu

Biochemical Pharmacology
|June 25, 2005
PubMed
Summary

Brain cholinergic systems, crucial for cognition and arousal, are vulnerable in diseases like Alzheimer's. Research highlights basal forebrain cholinergic complex (BFCC) degeneration, yet precise disease mechanisms remain elusive.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How Positive Psychology Can Augment Leadership Through the Therapeutic Alliance.

MedEdPORTAL : the journal of teaching and learning resources·2025
Same author

Practical aspects of radioligand binding.

Current protocols in pharmacology·2012
Same author

Altered expression of zonula occludens-2 precedes increased blood-brain barrier permeability in a murine model of fulminant hepatic failure.

Journal of investigative surgery : the official journal of the Academy of Surgical Research·2008
Same author

Pathway analysis of primary central nervous system lymphoma.

Blood·2008
Same author

Aging elevates metabolic gene expression in brain cholinergic neurons.

Neurobiology of aging·2007
Same author

Establishment of cholinergic neuron-like cell lines with differential vulnerability to nitrosative stress.

Current neurovascular research·2007

Area of Science:

  • Neuroscience
  • Neuroanatomy
  • Neurodegenerative Diseases

Background:

  • Two major brain cholinergic projection systems, pontine and basal forebrain, form part of the ascending reticular activating system (ARAS).
  • These systems globally influence cortical and hippocampal regions, regulating arousal, sleep-wake cycles, and cognitive functions.
  • Degeneration of the basal forebrain cholinergic complex (BFCC) is observed in conditions like Alzheimer's disease.

Purpose of the Study:

  • To review the anatomical substrates and functional roles of ascending cholinergic projections in the brain.
  • To discuss the implications of BFCC degeneration in human brain conditions, particularly Alzheimer's disease.
  • To explore proposed mechanisms underlying cholinergic vulnerability in disease.

Main Methods:

Related Experiment Videos

  • Review of over 50 years of research on brain cholinergic systems.
  • Analysis of anatomical connections and functional influences of pontine and basal forebrain cholinergic projections.
  • Examination of evidence regarding neuronal degeneration in Alzheimer's disease and other conditions.

Main Results:

  • The BFCC and pontine cholinergic system work in parallel to modulate cortical and hippocampal activity, impacting cognition and arousal.
  • While BFCC neurons degenerate in Alzheimer's, pontine projections appear relatively preserved.
  • Multiple hypotheses for BFCC degeneration exist, including growth factor deprivation, calcium dysfunction, and oxidative stress, but mechanisms are unclear.

Conclusions:

  • Ascending cholinergic projections play a critical role in global brain function and cognitive processes.
  • The vulnerability of BFCC neurons in neurodegenerative diseases like Alzheimer's highlights their importance.
  • Further research is needed to elucidate the precise mechanisms driving brain cholinergic vulnerability in human diseases.